Trade OraSure Technologies Inc - OSUR CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.03
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.02237 %(-$2.24)Trade size with leverage ~ $10,000.00Money from leverage ~ $$9,000.00Go to platform: -0.02237%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position0.00015 %($0.02)Trade size with leverage ~ $10,000.00Money from leverage ~ $$9,000.00Go to platform: 0.00015%
• Overnight funding adjustment time: 22:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 10.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.02237 %
  (-$2.24)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: 0.00015 %
  ($0.02)

Key Stats

• Prev. Close: 3.35
• Open: 3.31
• 1-Year Change: 29.3%
• Day's Range: 3.31 - 3.48

Trade OraSure Technologies Inc - OSUR

About OraSure Technologies, Inc.

OraSure Technologies, Inc. (OraSure) is a medical device company that develops, manufactures, and markets medical devices and diagnostic products. The Company's products include molecular sampling kits for the genome and microbiome services and analytics, rapid diagnostics for infectious disease, and tests for substance abuse. OraSure’s segments include Diagnostics segment and Molecular Collection Systems segment. The Diagnostics business primarily consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices. The Molecular Solutions business consists of the manufacture and sale of kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbiome and animal genetics markets.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, OraSure Technologies, Inc. revenues increased 36% to $233.7M. Net loss increased 54% to $23M. Revenues reflect Molecular Solutions segment increase of 35% to $143.6M, Diagnostics segment increase of 38% to $90M, United States segment increase of 44% to $188.4M, Other Regions segment increase of 9% to $31.5M, Europe segment increase of 14% to $13.8M.

Equity composition

Common Stock $.000001 Par, 03/11, 120M auth., 46,626,324 o/s. Insiders own 2.05%. 9/29/00, Company formed through pooling between Epitope and OraSure Technologies.